Related Experiment Video

Updated: Jul 18, 2025

Transverse Aortic Constriction in Mice
08:25

Transverse Aortic Constriction in Mice

Published on: April 21, 2010

67.2K

Triggering receptor expressed on myeloid cells 2 restricts cardiac inflammation and hypertrophy in hypertensive mice

Murilo Delgobo1,2, Stefan Frantz1,2

  • 1Department of Internal Medicine I, University Hospital Würzburg, Oberduerrbacher Str. 6, 97080 Würzburg, Germany.

Cardiovascular Research
|August 21, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Technique of Minimally Invasive Transverse Aortic Constriction in Mice for Induction of Left Ventricular Hypertrophy
08:34

Technique of Minimally Invasive Transverse Aortic Constriction in Mice for Induction of Left Ventricular Hypertrophy

Published on: September 25, 2017

24.5K
Minimally Invasive Transverse Aortic Constriction in Mice
07:40

Minimally Invasive Transverse Aortic Constriction in Mice

Published on: March 14, 2017

20.6K

Related Experiment Videos

Last Updated: Jul 18, 2025

Transverse Aortic Constriction in Mice
08:25

Transverse Aortic Constriction in Mice

Published on: April 21, 2010

67.2K
Technique of Minimally Invasive Transverse Aortic Constriction in Mice for Induction of Left Ventricular Hypertrophy
08:34

Technique of Minimally Invasive Transverse Aortic Constriction in Mice for Induction of Left Ventricular Hypertrophy

Published on: September 25, 2017

24.5K
Minimally Invasive Transverse Aortic Constriction in Mice
07:40

Minimally Invasive Transverse Aortic Constriction in Mice

Published on: March 14, 2017

20.6K

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

463
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
463
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

15
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
15

Articles linked to this work by shared authors, journal, and citation graph.

Cytomegalovirus Latency Fuels Inflammation Following Myocardial Infarction.

Circulation research·2026

Enhanced myelopoiesis and myeloid TREM1 upregulation link obesity with adverse outcomes after myocardial infarction.

Basic research in cardiology·2026

Effect Modification of Remote Patient Management by Sex and Marital Status Among Patients With Heart Failure in Germany: Findings From the Extended Interdisciplinary Network Heart Failure Trial.

Circulation. Population health and outcomes·2026

Longitudinal trajectories of neurodegenerative biomarkers in the blood of patients with chronic heart failure.

ESC heart failure·2026

Myocardial work analysis during semi-supine stress echocardiography: exercise response patterns in heart failure patients and controls.

European heart journal. Imaging methods and practice·2026

Interferon gamma signaling drives cardiac metabolic rewiring.

bioRxiv : the preprint server for biology·2025

Growth hormone and aging cardiomyocytes.

Cardiovascular research·2026

Macrophage Smad1 drives post-infarction dysfunction by reducing angiogenesis and by promoting matrix remodeling.

Cardiovascular research·2026

Distinct chromatin landscapes dictate resident cardiac macrophage lifecycles and functions.

Cardiovascular research·2026

Beyond the vessel wall: single-cell dissection of epicardial fat-myocardial crosstalk in coronary artery disease.

Cardiovascular research·2026

Redirecting full-length FLT1 expression towards its soluble isoform by targeting alternative polyadenylation promotes postischaemic angiogenesis.

Cardiovascular research·2026

Liver X receptor (LXR) signaling in macrophage inflammation and cardiometabolic disease.

Cardiovascular research·2026

Giant cardiac hemangioma: case report and literature review.

European heart journal. Case reports·2026

Integrated microarray-based and single-cell transcriptomic analyses reveal cell adhesion-related fibrotic remodeling signatures in heart failure.

Frontiers in molecular biosciences·2026

Development and validation of a machine learning model for predicting coronary artery disease risk: a retrospective study.

Frontiers in cardiovascular medicine·2026

Metabolic syndrome score and cardiovascular disease risk in adults with cardiovascular-kidney-metabolic syndrome stages 0-3: A prospective cohort study.

Metabolism open·2026

EHA Guidelines on the management of children and adults with hemoglobin SC disease.

HemaSphere·2026

A diagnostic and classification model integrating cTnI, CK-MB, MYO and NT-proBNP for cardiovascular diseases.

Experimental and therapeutic medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us